Palm Tocotrienols in Chronic Hemodialysis (USA)
Palm Tocotrienols in Chronic Hemodialysis (USA)
NCT ID: NCT02358967 Phase: NA Status: COMPLETED Enrollment: 280 Completion: 2020-08-31
Conditions
End Stage Renal Disease, Chronic Kidney Disease
Interventions
TRF (Tocotrienol-rich-fraction), Placebo
Summary
Patients undergoing chronic hemodialysis are at increased risk for cardiovascular disease, attributed in part to increased oxidative stress, inflammation and dyslipidemia. Intervention with a naturally occurring dietary supplement may improve certain biomarkers of inflammation and oxidative stress and improve the lipid profile.
Primary Outcome
Inflammatory markers